Methods for treating central nervous system disorders using optically pure (+) norcisapride
US5877188A · kind A · utility
11Cited by
7References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 1997 |
| Grant date | Mar 2, 1999 |
| Priority date | — |
| Expiry date | Aug 5, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods utilizing the optically pure (+) isomer of norcisapride are disclosed. This compound has surprisingly been found to be a potent drug for the treatment of disorders of the central nervous system. The compound, (+) norcisapride, has also been found to be a potent antiemetic agent. Finally, the (+) isomer of norcisapride also avoids certain adverse side effects and certain adverse drug interactions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.